British drug discovery specialist BenevolentAI Ltd has licenced its end-to-end AI platform capabilities to Merck KGaA to deliver novel drug candidates for three...
Duchenne muscular dystrophy (DMD) is a rare condition that is typically treated with the help of steroids, to manage symptoms, as scientists are yet...
Genesis Therapeutics, an AI Biotech Startup Supported by A16z, Secures $200M in FundingGenesis Therapeutics, a cutting-edge artificial intelligence (AI) biotech startup, has recently announced...
SHANGHAI, Aug. 11, 2023 /PRNewswire/ -- Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of...
MIRA Pharmaceuticals, a leading biopharmaceutical company, is set to ring the Nasdaq opening bell on Wednesday, August 25th. This prestigious event marks a significant...
Introduction
Generative artificial intelligence has gained sudden traction in the last few years. It is not surprising that there is becoming a strong attraction between...
British drug discovery specialist Sygnature Discovery Ltd has taken over Canadian NuChem Sciences Inc., one of North America’s largest discovery CROs ...
As the global pharmaceutical landscape continues to transform at a breathtaking pace, it becomes crucial to examine the phenomenon that is powering this change...
VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end...
Drug development is a complex and long process that involves screening thousands of drug candidates and using computational or experimental methods to evaluate leads....
